OMER
OMER
NASDAQ · Pharmaceuticals

Omeros Corp

$10.28
+0.64 (+6.64%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +533.9% upside
Low Target $47.12
Average Target $65.17
High Target $100.64
Current Price $10.28
Current
$10.28
Target
$65.17
$47.12 $65.17 avg $100.64
Scenario Analysis
Bear Case
$47.12
358.4%
Low target
Base Case
$65.17
+533.9%
Avg target
Bull Case
$100.64
+879.0%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$17.65
-41.8% from high
52-Week Low
$2.95
+248.5% from low
Target vs 52W High
$65.17
+269.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%